Found: 86
Select item for more details and to access through your institution.
Defining new paradigms for the treatment of pancreatic cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Innovation and beyond: Dangers in improvised negative pressure wound therapy systems.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Through the mists of time: Sushrutha, an enigma revisited.
- Published in:
- Indian Journal of Plastic Surgery, 2009, v. 42, n. 2, p. 219, doi. 10.1055/s-0039-1699347
- By:
- Publication type:
- Article
Phase I Study of Bryostatin 1: Assessment of Interleukin 6 and Tumor Necrosis Factor α Induction In Vivo.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1993, v. 85, n. 22, p. 1812, doi. 10.1093/jnci/85.22.1812
- By:
- Publication type:
- Article
Histopathologic Evidence of Tumor Regression in the Axillary Lymph Nodes of Patients Treated With Preoperative Chemotherapy Correlates With Breast Cancer Outcome.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2003, v. 10, n. 7, p. 734, doi. 10.1245/ASO.2003.03.081
- By:
- Publication type:
- Article
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 19, p. 4826, doi. 10.3390/ijms20194826
- By:
- Publication type:
- Article
Clinical Advances in Molecular Biomarkers for Cancer Diagnosis and Therapy.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 7, p. 147713, doi. 10.3390/ijms140714771
- By:
- Publication type:
- Article
Deciphering cellular plasticity in pancreatic cancer for effective treatments.
- Published in:
- Cancer & Metastasis Reviews, 2024, v. 43, n. 1, p. 393, doi. 10.1007/s10555-023-10164-5
- By:
- Publication type:
- Article
Pancreatic cancer: why we must be optimistic?
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 3, p. 659, doi. 10.1007/s10555-021-09994-y
- By:
- Publication type:
- Article
Targeting KRAS in pancreatic cancer: new drugs on the horizon.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 3, p. 819, doi. 10.1007/s10555-021-09990-2
- By:
- Publication type:
- Article
Gastrointestinal stromal tumor: a review of current and emerging therapies.
- Published in:
- Cancer & Metastasis Reviews, 2021, v. 40, n. 2, p. 625, doi. 10.1007/s10555-021-09961-7
- By:
- Publication type:
- Article
Repositioning of Tourism and Recreational Industry in Africa: The Case of Shrines and Sacred Places in Nigeria.
- Published in:
- KIU Journal of Social Sciences, 2023, v. 9, n. 4, p. 15
- By:
- Publication type:
- Article
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
- Published in:
- 2016
- By:
- Publication type:
- journal article
PURE TONE AUDIOMETRY with the mentally retarded.
- Published in:
- Exceptional Children, 1958, v. 24, n. 7, p. 303, doi. 10.1177/001440295802400702
- By:
- Publication type:
- Article
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 3, p. 1354, doi. 10.1245/s10434-022-12863-9
- By:
- Publication type:
- Article
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 8, p. 2787, doi. 10.1245/s10434-013-2886-9
- By:
- Publication type:
- Article
A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2006, v. 13, n. 2, p. 150, doi. 10.1245/ASO.2006.03.039
- By:
- Publication type:
- Article
CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2010, v. 6, n. 2, p. 98, doi. 10.1111/j.1743-7563.2010.01290.x
- By:
- Publication type:
- Article
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition.
- Published in:
- Scientific Reports, 2015, p. 16077, doi. 10.1038/srep16077
- By:
- Publication type:
- Article
Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017850
- By:
- Publication type:
- Article
Improving classification of crop residues using digital land ownership data and Landsat TM imagery
- Published in:
- Photogrammetric Engineering & Remote Sensing, 1991, v. 57, n. 11, p. 1487
- By:
- Publication type:
- Article
Biochemotherapy for melanoma.
- Published in:
- Current Oncology Reports, 2000, v. 2, n. 4, p. 314, doi. 10.1007/s11912-000-0024-x
- By:
- Publication type:
- Article
Medical Community Must Support More Research.
- Published in:
- Oncology (08909091), 2019, v. 33, n. 11, p. 456
- By:
- Publication type:
- Article
Systemic Therapy of Pancreatic Cancer: Better Science, Faster Progress.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 11, p. 821
- By:
- Publication type:
- Article
Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 189
- By:
- Publication type:
- Article
Concurrent inhibition of NF-κB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
- Published in:
- Journal of Cellular Biochemistry, 2010, v. 110, n. 1, p. 171, doi. 10.1002/jcb.22523
- By:
- Publication type:
- Article
A Post-International Gastrointestinal Cancers' Conference (IGICC) Position Statements.
- Published in:
- Journal of Hepatocellular Carcinoma, 2024, v. 11, p. 953, doi. 10.2147/JHC.S449540
- By:
- Publication type:
- Article
Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4161, doi. 10.3390/cancers13164161
- By:
- Publication type:
- Article
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2777, doi. 10.3390/cancers13112777
- By:
- Publication type:
- Article
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 750, doi. 10.3390/cancers12030750
- By:
- Publication type:
- Article
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors.
- Published in:
- Cancers, 2019, v. 11, n. 12, p. 1902, doi. 10.3390/cancers11121902
- By:
- Publication type:
- Article
DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1101, doi. 10.3390/cancers11081101
- By:
- Publication type:
- Article
Adjuvant Treatment of Surgically Resectable Pancreatic Ductal Adenocarcinoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 1, p. 54
- By:
- Publication type:
- Article
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 1, p. 387, doi. 10.1007/s10637-010-9532-1
- By:
- Publication type:
- Article
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 4, p. 694, doi. 10.1007/s10637-010-9386-6
- By:
- Publication type:
- Article
A phase I study of flavopiridol and docetaxel.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 4, p. 305, doi. 10.1007/s10637-005-4343-5
- By:
- Publication type:
- Article
A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 6, p. 583, doi. 10.1007/s10637-005-1028-z
- By:
- Publication type:
- Article
Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 1, p. 57, doi. 10.1023/B:DRUG.0000047106.20104.a7
- By:
- Publication type:
- Article
Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells.
- Published in:
- Breast Cancer Research & Treatment, 2005, v. 90, n. 1, p. 25, doi. 10.1007/s10549-004-2179-x
- By:
- Publication type:
- Article
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00694-8
- By:
- Publication type:
- Article
A randomized phase II study of SM‐88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 22, p. 4169, doi. 10.1002/cam4.4768
- By:
- Publication type:
- Article
The impact of primary tumor sidedness on survival in early‐onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 9, p. 2987, doi. 10.1002/cam4.3757
- By:
- Publication type:
- Article
Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 12, p. 1, doi. 10.1002/ctm2.1513
- By:
- Publication type:
- Article
High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.755113
- By:
- Publication type:
- Article
Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Phase II Trial of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 4, p. 770, doi. 10.1002/cncr.22857
- By:
- Publication type:
- Article
Consensus report of the International Society of Gastrointestinal Oncology on therapeutic progress in advanced pancreatic cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 4, p. 676, doi. 10.1002/cncr.22036
- By:
- Publication type:
- Article
Gemcitabine and platinum combinations in pancreatic cancer.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. S4, p. 908, doi. 10.1002/cncr.10757
- By:
- Publication type:
- Article
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.
- Published in:
- 2001
- By:
- Publication type:
- journal article